Breaking News

AZ Acquires DSM Bio-Facility in Montreal

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AstraZeneca has acquired DSM Biologics’ manufacturing facility in Montreal, Canada. The 66,000-sq.-ft. facility will be used to manufacture antibody drug candidates for AZ’s clinical trials. The facility will be re-commissioned and AZ plans to begin full-scale production in 2009. Leendert Staal, president and chief executive officer of DSM Pharmaceutical Products, commented, “We are very pleased with this transaction, hereby completing an important step in our Biologics st...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters